Results 281 to 290 of about 547,472 (401)

Transition from Squamous Cell Carcinoma to Adenocarcinoma in Adenosquamous Carcinoma of the Lung [PDF]

, 2000
Hironobu Kanazawa, Masahito Ebina, Nozomu Ino-oka, Minoru Shimizukawa, Toru Takahashi, Shigefumi Fujimura, Tadashi Imai, Toshihiro Nukiwa   +7 more
openalex   +1 more source

Adenocarcinoma of the lung

, 2017
openaire   +1 more source

Differences between lung adenocarcinoma and lung squamous cell carcinoma: Driver genes, therapeutic targets, and clinical efficacy. [PDF]

Genes Dis
Shen Y, Chen JQ, Li XP.
europepmc   +1 more source

Enhancer Reprogramming Reveals the Tumorigenic Role of PTPRZ1 in Lung Squamous Cell Carcinoma

Advanced Science, EarlyView.
Lung squamous cell cancer (LUSC) is deadly due to lack of good treatments. Here, multiomics techniques are applied to LUSC tumors and find thousands of cancer‐specific enhancers controlling key genes. Interestingly, the gene PTPRZ1 is identified as a critical oncogene driven by the LUSC‐acquired enhancers. PTPRZ1 is activated by MDK, fueling cancer via
Yong‐Qiang Ning, Jie Wang, Yihui Zhang, Hongrui Li, Zenan Jiang, Xinyu Su, Xiao Yang, Xiaoxuan Wu, Bing Wei, Jianmin Ying, Jian Yan, Wenbin Li   +11 more
wiley   +1 more source

Cigarette Filter Ventilation and its Relationship to Increasing Rates of Lung Adenocarcinoma

Journal of the National Cancer Institute, 2017
Min-Ae Song, N. Benowitz, Micah L. Berman, T. Brasky, K. Cummings, D. Hatsukami, C. Marian, Richard, O’Connor, V. Rees, Casper Woroszyło, P. Shields   +11 more
semanticscholar   +1 more source

Intravenous iRGD‐Guided, RBC‐Membrane Camouflaged Lactococcus Lactis Remodels Cold NSCLC and Enhances PD‐1 Blockade

Advanced Science, EarlyView.
This study presents an engineered probiotic platform, iRGD‐mRBC@FOLactis, combining red blood cell membrane cloaking and tumor‐penetrating peptide iRGD for enhanced PD‐1 blockade. The platform improves tumor targeting, immune cell activation and therapeutic efficacy in lung cancer, demonstrating significant promise in overcoming PD‐1/PD‐L1 therapy ...
Chen Chen, Junmeng Zhu, Xiao Liu, Jie Shao, Aoxing Chen, Yi Mei, Xinyin Zhang, Qinyi Chen, Lin Li, Baorui Liu   +9 more
wiley   +1 more source

An Autopsy Case of Cytokeratin 7-positive Minute Adenocarcinoma of the Lung with Systemic Metastases.

, 1998
Yumi Ise, Hiroaki Yanagawa, Takanori Hirose, Kenji Tani, Seiji Yano, Yoshihiro Suzuki, Eiji Takeuchi, Kouji Maniwa, Eiji Shimizu, Fumitaka Ogushi, Toshiaki Sano, Saburo Sone   +11 more
openalex   +2 more sources

Mutations and Reduced Expression of the Transforming Growth Factor‐β Receptor II Gene in Rat Lung Adenocarcinomas Induced by N‐Nitrosobis‐(2‐hydroxypropyl)amine [PDF]

, 2000
Toshifumi Tsujiuchi, Yasutaka Sasaki, Masahiro Tsutsumi, Yoichi Konishi   +3 more
openalex   +1 more source

Lung adenocarcinoma

, 2017
openaire   +1 more source

Posterior Subglottic Mass in a Patient With a History of Rectal Adenocarcinoma and Lung Metastases. [PDF]

JAMA Oncol, 2020
Craig F, O'Sullivan Coyne G, Allen CT.
europepmc   +1 more source